No Data
Towns --- a steady step into the microbiome market, capital business partnership with KINS.
Towns <197A>, one of the largest companies in infectious disease POCT (Point of Care Testing: simple rapid testing systems), manufactures in vitro diagnostic Pharmaceuticals and research reagents utilizing various diagnostic technologies, selling them domestically and internationally, has announced a capital and business alliance with KINS. The company is steadily advancing towards its goal of entering the chronic disease field, which it has been pursuing for some time. KINS is expected to generate early sales in its consumer Health Care business and clinic operations.
List of cloud breakout stocks (Part 1) [Ichimoku Kinko Hyo - List of cloud breakout stocks].
○ List of stocks that have broken through the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <1925> Daiwa House 4916 4909.5 4826 <2587> Suntory BF 4894 4734.5 4835.5 <2726> Pal HD 3405 3275 3214 <3475> Goodcom A 9338 66.7 5868 <4528> Ono Pharmaceutical 1629 1583.25 1622.
Eiken Chemical To Go Ex-Dividend On March 28th, 2025 With 27 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Eiken Chemical(4549.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 27 JPY dividend per share. The ex-
Eiken Chemical and Nippon Active's shareholding ratio has increased to 25.77%.
It has been revealed that the shareholding percentage of the Nippon Active Value Fund (Nippon Active) and its co-shareholders in Eiken Chemical Co., Ltd. <4549.T> has increased. Nippon Active submitted a large shareholding change report after the close on the 3rd. The shareholding percentage with co-shareholders rose from 24.69% at the time of the last submission to 25.77%. The purpose of the shareholding is stated to be investment and providing management advice to the management team, along with making significant proposals as circumstances dictate. The closing price on the 3rd was 1 compared to the weekend before.
Express News | [Change Report] NIPPON ACTIVE reported an increase in the shareholding ratio of Eiken Chemical (4549.JP) to 25.77%.
Eiken Chemical - a comprehensive manufacturer of clinical diagnostic reagents, holds the top Share in fecal occult blood test reagents and aims for growth through Overseas expansion and M&A implementation.
Eiken Chemical Co., Ltd. <4549> is a comprehensive manufacturer of clinical testing reagents, handling clinical test reagents and equipment used in various fields such as fecal occult blood tests for colorectal cancer screening, urine tests at Hospitals and health checkups, and diagnostic tests for infections. It offers a wide range of clinical testing reagents and equipment used in various diagnostics, including microbiological tests, immunoserological tests, and rapid tests (POCT), with its fecal occult blood test reagents and urine test reagents boasting the top Share in the domestic market. In Japan, it holds the leading share in fecal occult blood test reagents.